Literature DB >> 2025008

Leukaemia mortality among relatives of cystic fibrosis patients.

L N al-Jader1, R R West, J A Holmes, L Meredith, M C Goodchild, P S Harper.   

Abstract

A total of 219 families of patients with cystic fibrosis living in Wales were studied for the occurrence of other diseases and for cause of death, and the findings in relation to leukaemia are reported. There were eight deaths due to leukaemia, five of the myeloid type, in first and second degree relatives; this is significantly more than the expected on the basis of national age specific mortality rates. In comparison, mortality among siblings, parents, aunts and uncles, and grandparents from all causes was within the expected. Screening the five patients with myeloid leukaemia for the delta F508 mutation showed that four were carriers of this mutation. It is concluded that carriers of the delta F508 mutation may have an increased risk of developing acute myeloid leukaemia. This could happen through the direct effect of the cystic fibrosis gene itself, or through its influence on another gene, such as the met oncogene, or gene(s) involved in granulocyte function on the long arm of chromosome 7.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025008      PMCID: PMC1792876          DOI: 10.1136/adc.66.3.317

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

2.  Mechanism of met oncogene activation.

Authors:  M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; G F Vande Woude
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

3.  Mortality from leukaemia among relatives of patients with cystic fibrosis.

Authors:  L N al-Jader; R R West; M C Goodchild; P S Harper
Journal:  BMJ       Date:  1989-01-21

4.  Defective chemotaxis in monosomy-7.

Authors:  P Ruutu; T Ruutu; P Vuopie; T U Kosunen; A de la Chapelle
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

5.  Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement.

Authors:  P R Tempest; B R Reeves; N K Spurr; A J Rance; A M Chan; P Brookes
Journal:  Carcinogenesis       Date:  1986-12       Impact factor: 4.944

6.  Childhood bone marrow monosomy 7 syndrome: a familial disorder?

Authors:  W L Carroll; R Morgan; B E Glader
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

7.  Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping.

Authors:  J Kere; T Ruutu; K A Davies; I B Roninson; P C Watkins; R Winqvist; A de la Chapelle
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

8.  The human met oncogene is related to the tyrosine kinase oncogenes.

Authors:  M Dean; M Park; M M Le Beau; T S Robins; M O Diaz; J D Rowley; D G Blair; G F Vande Woude
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

9.  TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.

Authors:  N R Soman; G N Wogan; J S Rhim
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Cystic fibrosis complicated by acute leukemia.

Authors:  B G Biggs; W Vaughan; J L Colombo; W Sanger; D T Purtilo
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

View more
  1 in total

1.  Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma.

Authors:  N Warren; J A Holmes; L al-Jader; R R West; D C Lewis; R A Padua
Journal:  BMJ       Date:  1991-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.